Matt Troyer – Biography
Last update: 2 days agoExecutive profile
Matt was Executive Director, Early Stage Development at Merck, and Principal Clinical Director at Denali Therapeutics.
Matt Troyer is currentlySenior Vice President and Head of Translational Medicine & Early Clinical Development at Denali Therapeutics - View - Denali Therapeutics org chart
Create your alert
to follow the career of Matt Troyer.
Education
Matt Troyer has a Master from Stanford Medical School.
More about Matt Troyer
Do you need to know more about Matt Troyer? More results.
Participate
Social media
- Matt Troyer on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Matt Troyer
The colleagues of Matt Troyer
Company Colleagues
- At Denali Therapeutics, Matt Troyer has 25 colleagues including Ryan Watts (CEO & Director), David Schenkein (Director)…
Industry Colleagues
- In the Biotechnology industry, Matt Troyer has 35,763 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Matt Troyer.
Get in Touch
Here are a few tips for establishing great contacts.
